Evonile Pharma Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 63.79 | 112.55 | 100.56 |
| Operating Expense | 156.13 | 68.90 | 69.93 |
| Net Profit | -77.54 | 32.21 | 25.25 |
| Net Profit Margin | -121.56% | 28.62% | 25.11% |
| Earning Per Share | -31.41 | 13.05 | 10.23 |
| EBIDTA | -80.28 | 44.15 | 28.67 |
| Effective Tax Rate | 12.41% | 26.25% | 9.57% |
Particulars
Sep 2026
Revenue63.79
Operating Expense156.13
Net Profit-77.54
Net Profit Margin-121.56
Earning Per Share-31.41
EBIDTA-80.28
Effective Tax Rate12.41
